![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Bischoff Lindsay A Jabbour Serge A Miller Jeffrey L
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.12, Iss.8, 2011-06, pp. : 1297-1303
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Weekly exenatide works wonders for type 2 diabetes
Inpharma, Vol. 1, Iss. 1656, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Exenatide Extended-Release: A Review of Its Use in Type 2 Diabetes Mellitus
Drugs, Vol. 72, Iss. 12, 2012-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Exenatide enhances standard therapy in type 2 diabetes mellitus
Inpharma, Vol. 1, Iss. 1445, 2004-01 ,pp. :